Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewSouthern Capital is a private equity firm headquartered in Memphis, Tennessee, that focuses on lower middle-market investments in the Southeastern United States. The firm primarily targets companies within the healthcare services, medical technology, and specialty distribution sectors. By partnering with established management teams, NewSouthern Capital provides the strategic resources and capital necessary to accelerate growth and operational excellence. Their investment approach is characterized by a deep commitment to regional economic development and long-term value creation. The firm leverages its extensive network and industry expertise to support the scaling of its portfolio companies, aiming to build sustainable market leaders with proven business models.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewSouthern Capital.